BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22012040)

  • 1. Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients.
    Neuenschwander LC; Bittencourt H; Ribeiro AF; Teixeira AL; Teixeira MM; Teixeira JC; Nobre V
    Clinics (Sao Paulo); 2011; 66(10):1699-705. PubMed ID: 22012040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia.
    Hatzistilianou M; Rekliti A; Athanassiadou F; Catriu D
    Inflamm Res; 2010 May; 59(5):339-47. PubMed ID: 19806318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever.
    Bilgir O; Bilgir F; Kebapcilar L; Bozkaya G; Çalan M; Kırbıyık H; Avci M; Sari İ; Yuksel A; Isikyakar T
    Transfus Apher Sci; 2012 Feb; 46(1):19-24. PubMed ID: 22079264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
    Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
    Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
    Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
    Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.
    García de Guadiana-Romualdo L; Español-Morales I; Cerezuela-Fuentes P; Consuegra-Sánchez L; Hernando-Holgado A; Esteban-Torrella P; Jiménez-Santos E; Viqueira-González M; de Béjar-Almira Á; Albaladejo-Otón MD
    Support Care Cancer; 2015 Jul; 23(7):2175-82. PubMed ID: 25564222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
    Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
    Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
    Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.
    Miedema KG; de Bont ES; Elferink RF; van Vliet MJ; Nijhuis CS; Kamps WA; Tissing WJ
    Support Care Cancer; 2011 Oct; 19(10):1593-600. PubMed ID: 20803037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
    Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
    Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.
    Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U
    Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
    Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
    Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
    Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
    Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
    J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin concentrations in patients with neutropenic fever.
    Ruokonen E; Nousiainen T; Pulkki K; Takala J
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):283-5. PubMed ID: 10385017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia.
    Ribeiro AF; Nobre V; Neuenschwander LC; Teixeira AL; Xavier SG; Paula FD; Teixeira MM; Teixeira JC; Bittencourt H
    Braz J Med Biol Res; 2013 Feb; 46(2):200-6. PubMed ID: 23369970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
    Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
    Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
    von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults.
    Massaro KS; Costa SF; Leone C; Chamone DA
    BMC Infect Dis; 2007 Nov; 7():137. PubMed ID: 18034890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.